Wolowacz SE. Economic analysis of macugen for age-related macular degeneration. Poster presented at the Royal College of Surgeons; February 2, 2007. London, England.
Abstract not available at this time
Ophthalmology
Arana A, Arellano FM, Rivero E, Parvesi M, Dey D, Wentworth CE. Intravitreal (IVT) injectionrelated ocular adverse events in the general population of the United States of America. Presented at the 24th International Conference on Pharmacoepidemiology; 2008.
Abstract not available at this time
Hill AR, Aspinall P, Armbrecht A, Lumsden C, Nelson P, Brice R, Vickers AD. Utilities for quality of life from time trade-off and conjoint analysis in age-related macular degeneration. Poster presented at the Heriott Watt University; 2004.
Abstract not available at this time
Nicholls TJ, Cook JD, Rogers DJ, Wolowacz SE, Smart JD. The effect of exposure time and washing on the binding of two lectins to tissues from the precorneal region of rats. Poster presented at the British Pharmaceutical Society; 1994.
Abstract not available at this time
Nicholls TJ, Carpenter BG, Rogers DJ, Cook DJ, Wolowacz SE, Smart JD. An investigationn of lectin binding sites on unfixed corneal and conjunctival surfaces of rats. Poster presented at the Proceedings of IinterLec; 2004.
Abstract not available at this time.
Wolowacz SE, Hamid O, Jones D, Lazare R. Ocular bioavailability of topical triamterene in the conscious rabbit by a non-invasive method. Poster presented at the British Toxicology Society meeting; April 1992. York, United Kingdom.
Abstract not available at this time
Nicholls TJ, Green KL, Cook DJ, Rogers DJ, Wolowacz SE, Smart JD. An investigation of lectins for use in ophthalmic drug delivery. Int J Pharm. 1996;138(2):175-83.
Ocular drug delivery is limited both by patient acceptability and by the limited time that the dosage form is retained within the precorneal region. The aim of this investigation was to identify lectin receptors within the precorneal region as potential targets for a lectin containing ocular dosage form, thus facilitating prolonged drug delivery. Initial ex-vivo studies evaluated the binding, after 15 min contact with intact (unfixed) rat corneal and conjunctival epithelia, of a panel of 36 lectins of varying sugar specificities. Tissues were sectioned and examined using light microscopy.
Nicholls TJ, Cook DJ, Rogers DJ, Wolowacz SE, Smart JD. An investigation of lectin toxicity with cultured human conjunctival epithelial cells; lectins: biology biochemistry. Clin Chem. 1996;11:273-6.
Abstract not available at this time.
Nicholls TJ, Cook DJ, Rogers DJ, Wolowacz SE, Smart JD. An investigation of lectin binding sites within the precorneal region. J Pharm Pharmacol. 1994;46:1050.
Abstract not available at this time.
Javitt JC, Zlateva GP, Earnshaw SR, Pleil AM, Graham CN, Brogan AJ. Cost-effectiveness model for age-related macular degeneration: comparing Macugen® to Visudyne®. Poster presented at the 2006 World Ophthalmology Congress; February 2006. Previously presented at the ISPOR 8th Annual European Congress.
Abstract not available at this time